FindTrial
Sign In

Exploring the Pathogenesis and Prevention/Treatment of Photodermatosis-Induced Vitiligo

Exploring the Pathogenesis and Prevention/Treatment of Photodermatosis-Induced Vitiligo

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500114752
Enrollment
Unknown
Registered
2025-12-17
Start date
2026-01-15
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vitiligo

Interventions

Observation group:None

Sponsors

The First Affiliated Hospital of Kunming Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Age 18-70 years; 2. Clearly diagnosed with vitiligo by at least two experienced attending dermatologists.

Exclusion criteria

Exclusion criteria: 1. Systemic diseases or mental disorders that severely affect quality of life and mental factors; 2. No systematic use of glucocorticoid drugs and/or immunosuppressants within 1 month before testing, and the test site has not been directly exposed to sunlight within 3 months.

Design outcomes

Primary

MeasureTime frame
Melanocyte Function;Oxidative Stress Level Indicators;Cytokine and Signaling Pathway Indicators;—

Countries

China

Contacts

Public ContactSun Dongjie

The First Affiliated Hospital of Kunming Medical University

412633947@qq.com+86 136 6975 7601

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026